Rob is the Director, Global Indication Lead at Janssen Oncology. Rob, an incredible athlete, became a strong cyclist in 2017 when he joined the inaugural R2V team on the 8-day “Desert Ride” from LA toFlagstaff, AX. In 2018, he re-upped his commitment rode on the Red Rocks team through Utah in 2018. He is back for 2019! Rob saysRoad to Victories empowers the patients who ride in the event to make a difference and allows those of us who get to know them to work even harder to find a cure.”
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.
About Janssen Oncology